Pooja Toshniwal Paharia

Pooja Toshniwal Paharia

M.D.S (OMR) - Masters in Dental Surgery (Oral Medicine and Radiology)

Oral Medicine, Radiology

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders. Her expertise involves diagnosing and managing potentially malignant as well as malignant lesions and conditions, temporomandibular joint disorders, orofacial pain conditions, salivary gland disorders, developmental anomalies, dental management of systemic conditions and medical emergencies, etc. using conservative treatments inclusive of medications, physiotherapy, biofeedback coupled gold standards such as surgical excisions and advanced techniques such as low-level laser therapy and transcutaneous electric nerve stimulation.

See more

During her post-graduation, she received accolades at several national and international conferences for her scientific research papers and the Academic Excellence Award for two consecutive years at her educational institute. Her field of interest has always been the use of advanced and non-invasive novel diagnostic as well as therapeutic techniques for maxillofacial disorders to provide an improved standard of care to patients. She has worked extensively on several research projects based on molecular spectroscopic analysis of proteins and nucleic acids and radiological assessment of morphological alterations correlated with disease severity in potentially malignant conditions. She has also worked on systematic reviews on the immunological management of Sjogren’s syndrome using novel monoclonal antibodies. As part of her post-graduation curriculum, she has undertaken several scientific writing assignments based on weekly reviews of constantly updated scientific literature published in peer-reviewed medical journals.

She is currently working as a consultant oral and maxillofacial radiologist at an advanced dental diagnostic center in India and provides three-dimensional and accurate radiological diagnostic information to doctors and patients on several dental conditions. Pooja is passionate about writing and dental health. Outside of work, she enjoys art, music, traveling, reading, and cooking.

See less

Articles from Pooja Toshniwal Paharia

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans

The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans

The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization

The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization

Exercise reduces COVID-19 severity risk

Exercise reduces COVID-19 severity risk

Dapagliflozin improves morbidity reduces risk of death in heart failure patients

Dapagliflozin improves morbidity reduces risk of death in heart failure patients

Excess COVID-19-associated death estimates by World Health Organization

Excess COVID-19-associated death estimates by World Health Organization

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.